Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Rectal Foam in Pediatric Patients With Active, Mild to Moderate Distal Ulcerative Colitis
NCT05976802Phase 4Not yet recruiting
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jun 2029
- Primary completion
- Jun 2030
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of budesonide in ulcerative colitis (UC), sponsored by Valeant Pharmaceuticals. Planned start Jun 2029; status: not yet recruiting.
02
Drugs
budesonide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05976802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05976802.